glp-1 drugs and dementia Might Cut Risk in Half An analysis on the role
Description
Semaglutide acts like human glucagon-like peptide-1 (GLP-1), in that it increases insulin secretion which thereby increases sugar metabolism

Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al

Type 2 diabetes mellitus (T2DM) is one of the major subtypes of DM, and its pathogenesis is more complex, involving insulin resistance and insulin secretion dysfunction (Xourafa et al., 2024)
Switching to an oral pill may appeal to those who dislike injections or want a simpler dosing routine, while a lower injectable dose may offer a cheaper option that may also result in less adverse events

10.1056/NEJMoa2413258 89 SawadaN.AdachiK.NakamuraN.MiyabeM.ItoM.KobayashiS.et al (2020)

Nutritious products must be accessible to GLP-1 users to achieve healthy eating habits that provide essential nutrients, vitamins, and minerals
